EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C57H96O28 |
| Net Charge | 0 |
| Average Mass | 1229.367 |
| Monoisotopic Mass | 1228.60881 |
| SMILES | [H][C@@]12CCC3C[C@@H](O[C@@H]4O[C@H](CO)[C@@H](O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O[C@@H]6OC[C@@H](O)[C@H](O)[C@H]6O)[C@H]5O[C@@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)CC[C@]3(C)[C@@]1([H])CC[C@@]1(C)[C@@]2([H])C[C@]2([H])O[C@@](CCC(C)CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)(OC)[C@@H](C)[C@]12[H] |
| InChI | InChI=1S/C57H96O28/c1-22(20-75-50-44(71)40(67)37(64)31(16-58)78-50)8-13-57(74-5)23(2)35-30(85-57)15-28-26-7-6-24-14-25(9-11-55(24,3)27(26)10-12-56(28,35)4)77-52-46(73)42(69)47(34(19-61)81-52)82-54-49(84-53-45(72)41(68)38(65)32(17-59)79-53)48(39(66)33(18-60)80-54)83-51-43(70)36(63)29(62)21-76-51/h22-54,58-73H,6-21H2,1-5H3/t22?,23-,24?,25-,26+,27-,28-,29+,30-,31+,32+,33+,34+,35-,36-,37+,38+,39+,40-,41-,42+,43+,44+,45+,46+,47+,48-,49+,50+,51-,52+,53-,54-,55-,56-,57+/m0/s1 |
| InChIKey | QOKZNLCOQRNCTQ-XFBOQIBUSA-N |
| Species of Metabolite | Component | Source | Comments |
|---|---|---|---|
| Brunfelsia grandiflora (ncbitaxon:1035550) | leaf (BTO:0000713) | PubMed (18175984) |
| Roles Classification |
|---|
| Biological Roles: | metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. antileishmanial agent An antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania. metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| Application: | antileishmanial agent An antiprotozoal drug used to treat or prevent infections caused by protozoan parasites that belong to the genus Leishmania. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 22α-methoxy-3-β-O-{β-D-Xylp(1→3)-[β-D-Glcp-(1→2)]-β-D-Glcp-(1→4)-β-D-Glcp}-furost-3β,26-diol 26-O-β-D-Glcp (CHEBI:65534) has parent hydride furostan (CHEBI:24130) |
| 22α-methoxy-3-β-O-{β-D-Xylp(1→3)-[β-D-Glcp-(1→2)]-β-D-Glcp-(1→4)-β-D-Glcp}-furost-3β,26-diol 26-O-β-D-Glcp (CHEBI:65534) has role antileishmanial agent (CHEBI:70868) |
| 22α-methoxy-3-β-O-{β-D-Xylp(1→3)-[β-D-Glcp-(1→2)]-β-D-Glcp-(1→4)-β-D-Glcp}-furost-3β,26-diol 26-O-β-D-Glcp (CHEBI:65534) has role metabolite (CHEBI:25212) |
| 22α-methoxy-3-β-O-{β-D-Xylp(1→3)-[β-D-Glcp-(1→2)]-β-D-Glcp-(1→4)-β-D-Glcp}-furost-3β,26-diol 26-O-β-D-Glcp (CHEBI:65534) is a steroid saponin (CHEBI:61655) |
| IUPAC Name |
|---|
| (3β,22R)-26-(β-D-glucopyranosyloxy)-22-methoxyfurostan-3-yl β-D-glucopyranosyl-(1→2)-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranosyl-(1→4)-β-D-glucopyranoside |
| Synonym | Source |
|---|---|
| 26-O-β-D-glucopyranosyl 22α-methoxyfurost-3β,26-diol 3-O-β-D-xylopyranosyl(1→3)-{β-D-glucopyranosyl(1→2)}-β-D-glucopyranosyl(1→4)-β-D-glucopyranoside | ChEBI |
| Citations |
|---|